Ignite Creation Date:
2025-12-24 @ 11:52 PM
Ignite Modification Date:
2026-03-06 @ 12:27 AM
Study NCT ID:
NCT04265651
Status:
COMPLETED
Last Update Posted:
2025-10-22
First Post:
2020-01-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Infigratinib in Children With Achondroplasia
Sponsor:
QED Therapeutics, a BridgeBio company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
QBGJ398-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None